Legal Representation
Attorney
Don Cha
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jun 6, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Feb 20, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 20, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 20, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 23, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 28, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 28, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 28, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 18, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 18, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 18, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 18, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 18, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 18, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 27, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for animal food, pharmaceutical drug and supplement for animal and human to promote beneficial gut bacteria; Probiotic animal feed; Probiotic supplements; Nutritional supplements, namely, probiotic compositions
First Use Anywhere:
Mar 4, 2019
First Use in Commerce:
Mar 4, 2019
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"